Faktor Pendukung Dan Penghambat Implementasi Terapi Pencegahan Tuberkulosis (TPT): Studi Literatur
DOI:
https://doi.org/10.64931/jks.v5i2.187Keywords:
Terapi Pencegahan Tuberkulosis, TPT, TB Laten, Faktor Pendukung, Faktor PenghambatAbstract
Saat ini, Indonesia berada di peringkat kedua di dunia dalam hal kontribusi kasus Tuberkulosis (TB) global, di belakang India, dengan 9,2%. Sebenarnya, TB adalah penyakit menular yang dapat diobati dan dapat dicegah. Upaya pencegahan penularan TB melalui implementasi Terapi Pencegahan Tuberkulosis (TPT) telah dilakukan dalam beberapa tahun terakhir, namun pencapaiannya masih jauh dari target nasional. Oleh karena itu, tinjauan literatur ini bertujuan untuk mengidentifikasi faktor penghambat dan pendukung dalam implementasi TPT. Studi ini menggunakan pendekatan narrative revier dengan pencarian literatur melalui PubMed dan Google Scholar menggunakan kata kunci dalam bahasa Inggris dan Bahasa Indonesia. Literatur yang berupa artikel asli, diterbitkan dalam 10 tahun terakhir, dapat diakses sepenuhnya dan memiliki konten yang relevan akan dikumpulkan dan diperiksa duplikasinya. Literatur terpilih kemudian disintesis. Sebanyak 18 artikel dipilih untuk ditinjau dan disintesis. Faktor pendukung dan penghambat implementasi TPT dari perspektif tenaga kesehatan, meliputi aspek pengetahuan, kapasitas, logistik, dan sistem pendukung. Berdasarkan perspektif kontak TB dan pengasuh anak yang kontak, faktor pendukung dan penghambat penerimaan TPT meliputi pengetahuan, akses, kepatuhan, keuntungan, kerugian, dan sistem pendukung. Kemudian dari perspektif pemangku kepentingan, faktor pendukung dan penghambat implementasi TPT adalah prioritas dan aspek logistik. Studi ini tidak secara khusus mencari literatur yang diperoleh dari Indonesia, sehingga dalam beberapa kasus, mungkin memberikan gambaran yang kurang sesuai dengan kondisi terkini di Indonesia.
References
Ahmed, A. A., Grammatico, M., Moll, A. P., Malinga, S., Makhunga, P., Charalambous, S., Ladines-Lim, J. B., Jones, J., Choi, K., & Shenoi, S. V. (2021). Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Global Health Action, 14(1). https://doi.org/10.1080/16549716.2021.1979281
An, Y., Teo, A. K. J., Huot, C. Y., Tieng, S., Khun, K. E., Pheng, S. H., Leng, C., Deng, S., Song, N., Nonaka, D., & Yi, S. (2023). They do not have symptoms – why do they need to take medicines? Challenges in tuberculosis preventive treatment among children in Cambodia: a qualitative study. BMC Pulmonary Medicine, 23(1), 1–8. https://doi.org/10.1186/s12890-023-02379-7
Ayieko, J., Abuogi, L., Simchowitz, B., Bukusi, E. A., Smith, A. H., & Reingold, A. (2014). Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: A meta-analysis. BMC Infectious Diseases, 14(1). https://doi.org/10.1186/1471-2334-14-91
Baloyi, D. P., Anthony, M. G., Meyerson, K. A., Mazibuko, S., Wademan, D., Viljoen, L., Myburgh, H., Preez, K. du, Osman, M., Hirsch-Moverman, Y., Charalambous, S., Hausler, H., Hesseling, A. C., Hoddinott, G., & on behalf of the Desmond Tutu TB Centre. (2022). Reasons for poor uptake of TB preventive therapy in South Africa. Public Health Action, 12(1). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716815/
Barberis, I., Bragazzi, N. L., Galluzzo, L., & Martini, M. (2017). The history of tuberculosis: From the first historical records to the isolation of Koch’s bacillus. Journal of Preventive Medicine and Hygiene, 58(1), E9–E12.
Birungi, F. M., Graham, S. M., Uwimana, J., Musabimana, A., & Van Wyk, B. (2019). Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study. PLoS ONE, 14(2), 1–16. https://doi.org/10.1371/journal.pone.0211934
Chandra, D. K., Moll, A. P., Altice, F. L., Didomizio, E., Andrews, L., & Shenoi, S. V. (2022). Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Global Public Health, 17(4), 555–568. https://doi.org/10.1080/17441692.2021.1892793
Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. (2023). Laporan Program Penanggulangan Tuberkulosis Tahun 2022. Kemenkes RI, 1–156. https://tbindonesia.or.id/pustaka_tbc/laporan-tahunan-program-tbc-2021/
Direktorat Jenderal Pencegahan dan Pengendalian Penyakit Direktorat Pencegahan dan Pengendalian Penyakit Menular Kementerian Kesehatan RI. (2017). Modul Pelatihan Penanggulangan Tuberkulosis (TBC) bagi Petugas Kesehatan di Fasyankes Tingkat Pertama (FKTP) Materi Inti 1: Penemuan Pasien Tuberkulosis. Kementerian Kesehatan RI.
Goroh, M. M. D., van den Boogaard, C. H. A., Lukman, K. A., Lowbridge, C., Juin, W. K., William, T., Jeffree, M. S., & Ralph, A. P. (2023). Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: A qualitative study. PLoS ONE, 18(5 May), 1–16. https://doi.org/10.1371/journal.pone.0285534
J. Boffa, M. Mayan, S. Ndlovu, D. Fisher, S. Staples, R. Sauve, T. W. (2019). When prevention is dangerous: perceptions of isoniazid preventive therapy in KwaZulu-Natal, South Africa. Public Health Action, 9(1), 24–31. http://dx.doi.org/10.5588/pha.16.0125%0ASetting:
Jacobson, K. B., Niccolai, L., Mtungwa, N., Moll, A. P., & Shenoi, S. V. (2017). “It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 29(7), 936–942. https://doi.org/10.1080/09540121.2017.1283390
Kasibante, J., Rutakingirwa, M. K., Kagimu, E., Ssebambulidde, K., Ellis, J., Tugume, L., Mpoza, E., Cresswell, F., & Meya, D. B. (2020). Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: A clinician’s perspective. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 20, 100180. https://doi.org/10.1016/j.jctube.2020.100180
Komba, F. F., & Frumence, G. (2021). Facility and patient barriers in the implementation of isoniazid preventive therapy for people living with HIV attending care and treatment centers, Songea municipality, Tanzania. Pan African Medical Journal, 38(1), 1–16. https://doi.org/10.11604/pamj.2021.38.197.26752
Lester, R., Hamilton, R., Charalambous, S., Dwadwa, T., Chandler, C., Churchyard, G. J., & Grant, A. D. (2010). Barriers to implementation of isoniazid preventive therapy in HIV clinics: A qualitative study. Aids, 24(SUPPL. 5), 45–48. https://doi.org/10.1097/01.aids.0000391021.18284.12
Mindachew, M., Deribew, A., Memiah, P., & Biadgilign, S. (2014). Perceived barriers to the implementation of isoniazid preventive therapy for people living with HIV in resource constrained settings: A qualitative study. Pan African Medical Journal, 17, 1–6. https://doi.org/10.11604/pamj.2014.17.26.2641
Ngugi, S. K., Muiruri, P., Odero, T., & Gachuno, O. (2020). Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: A mixed quantitative and qualitative study. BMC Infectious Diseases, 20(1), 1–11. https://doi.org/10.1186/s12879-020-05011-9
Nyarubamba, R. F., Silumbwe, A., Jacobs, C., Maritim, P., Mdoe, P., & Zulu, J. M. (2022). Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania. BMC Infectious Diseases, 22(1), 1–9. https://doi.org/10.1186/s12879-022-07867-5
Rakhmawati, W., Nilmanat, K., & Hatthakit, U. (2019). Moving from fear to realization: Family engagement in tuberculosis prevention in children living in tuberculosis Sundanese households in Indonesia. International Journal of Nursing Sciences, 6(3), 272–277. https://doi.org/10.1016/j.ijnss.2019.06.002
Reddy, M. M., Thekkur, P., Ramya, N., Kamath, P. B. T., Shastri, S. G., Kumar, R. B. N., Chinnakali, P., Nirgude, A. S., Rangaraju, C., Somashekar, N., & Kumar, A. M. V. (2020). To start or to complete?–Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India. Global Health Action, 13(1). https://doi.org/10.1080/16549716.2019.1704540
Russom, M., Woldu, H. G., Berhane, A., Jeannetot, D. Y. B., Stricker, B. H., & Verhamme, K. (2022). Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study. Infectious Diseases and Therapy, 11(1), 559–579. https://doi.org/10.1007/s40121-022-00589-w
Ssendikwanawa, E., Juniour Nsubuga, E., Lee, S., Frances Zalwango, J., Joan Bayowa, R., Judith Ssemasaazi, A., Ronald Muganga, K., Adolphus, C., Akunzirwe, R., Nante Wangi, R., Ronald Kasoma, M., Kalyango, J. N., Karamagi, C., & Sekaggya-Wiltshire, C. (2023). Factors associated with isoniazid preventive treatment interruption and completion among PLHIV in Gombe Hospital, Uganda, 2017–2019. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 31(January), 100349. https://doi.org/10.1016/j.jctube.2023.100349
Tahan, T. T., Rossoni, A. M. de O., Bedim dos Santos, M., da Silveira, J. T. P., de Oliveira, S. P., & Rodrigues, C. de O. (2023). Tuberculosis preventive treatment in children and adolescents: an observational study of secondary data. Jornal de Pediatria, 99(4), 399–405. https://doi.org/10.1016/j.jped.2023.02.002
Teklay, G., Teklu, T., Legesse, B., Tedla, K., & Klinkenberg, E. (2016). Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: A mixed quantitative and qualitative study. BMC Public Health, 16(1), 1–9. https://doi.org/10.1186/s12889-016-3525-8
Tim Kerja Tuberkulosis. (2023). Dashboard Data Kondisi TBC di Indonesia Data Diperbarui 2 November 2023. https://tbindonesia.or.id/pustaka-tbc/dashboard
Wambiya, E. O. A., Atela, M., Eboreime, E., & Ibisomi, L. (2018). Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: A qualitative study. BMJ Open, 8(12), 1–10. https://doi.org/10.1136/bmjopen-2018-024286
World Health Organization. (2020). A situational analysis of Programmatic Management of TB Preventive Treatment.
Hirsch-Moverman, Y., Shrestha-Kuwahara, R., Bethel, J., Blumberg, H. M., Venkatappa, T. K., Horsburgh Jr, C. R., & Colson, P. W. (2015). Latent tuberculous infection in the United States and Canada: Who completes treatment and why? International Journal of Tuberculosis and Lung Disease, 19(1), 31–38. https://doi.org/10.5588/ijtld.14.037
Yanes-Lane, M., Trajman, A., Bastos, M. L., Oxlade, O., Valiquette, C., Rufino, N., Fregonese, F., & Menzies, D. (2021). Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation. BMC Public Health, 21(1), 1–8. https://doi.org/10.1186/s12889-021-10195-z
Zawedde-Muyanja, S., Manabe, Y. C., Cattamanchi, A., Castelnuovo, B., & Katamba, A. (2022). Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study. BMC Health Services Research, 22(1), 1–14. https://doi.org/10.1186/s12913-022-08213-w
Zhou, G., Luo, S., He, J., Chen, N., Zhang, Y., Cai, S., Guo, X., Chen, H., & Song, C. (2023). Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Clinical Microbiology and Infection, xxxx. https://doi.org/10.1016/j.cmi.2023.09.015
